{"@id":"https://bioecon.ru/technology/therapeutic-mitochondria-transplantation/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/therapeutic-mitochondria-transplantation/","json":"https://cn.bioecon.ru/api/v1/technology/therapeutic-mitochondria-transplantation/index.json"},"id":"therapeutic-mitochondria-transplantation","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/amazentis/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/united-therapeutics/","https://bioecon.ru/companies/codexis/","https://bioecon.ru/companies/bioage-labs/","https://bioecon.ru/companies/fountain-life/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/isomorphic-labs/"]},"maturity":6,"name":"缺血应激细胞治疗性线粒体分离与移植技术","regions":["ch","eu","us","cn"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"低温温和机械匀浆与差异离心"},{"n":2,"title":"高分辨呼吸控制率活性质控"},{"n":3,"title":"导管引导局部或微血管注射"},{"n":4,"title":"微胞饮内吞整合与能量重启"}],"summary":"从健康自体或异体细胞中高效分离、质控并纯化具备呼吸活性的完整线粒体，原位或经血管灌注移植至缺血受损心肌或脑组织细胞内，重启能量代谢并阻断细胞凋亡。","url":"/technology/therapeutic-mitochondria-transplantation/","verified":"2026-11-22"}